Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Zimmer

How Is Zimmer Biomet Holdings' Stock Performance Compared to Other Medical Device Stocks?

Zimmer Biomet Holdings has significantly underperformed other medical device stocks over the past year, yet analysts remain optimistic about the stock’s prospects.

Barchart

2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead

Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance.

MarketBeat

Here's What to Expect From Zimmer Biomet Holdings' Next Earnings Report

Zimmer Biomet Holdings is expected to release its third-quarter earnings later this month, and analysts expect a single-digit earnings growth.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Health-Care Stocks Have Outperformed; Here Are a Few Undervalued.

The S&P 500 Healthcare index gained 4.8% during the past 12 months, versus a 6% dip for the S&P 500 as a whole.

The Street

Hallmark and Hanukkah aren't beshert

All the dreidels, latkes and Yiddish feels less like representation and more like reinforcing antisemitic tropes

Salon

Teen Deadlifter Gets Back To The Gym After Surviving Cancer That Paralyzed Him

Following chemotherapy, he slowly began to regain movement and began to teach himself to walk again.

Zenger

SVB Leerink Maintains Outperform Rating for Zimmer Biomet Holdings: Here's What You Need To Know

SVB Leerink has decided to maintain its Outperform rating of Zimmer Biomet Holdings (NYSE:ZBH) and raise its price target from $135.00 to $140.00. Shares of Zimmer Biomet Holdings are trading up 0.82% over the last 24 hours, at $121.67 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Vicky Phelan says she is now in 'manageable pain' in positive social media update as she enjoys afternoon tea with her mum

Vicky announced that she was back walking on her "own two feet" without the help of a Zimmer frame or a wheelchair

Irish Mirror

Zimmer Biomet: The Pandemic Just Squeezed Another Medical Devices Stock

Zimmer Biomet stock tumbled Monday after the firm blamed the Covid pandemic for light fourth-quarter earnings and 2022 guidance.

Investors Business Daily

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Zimmer Biomet Holdings

14 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.